Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	297.74	61.12	80.24	74.02	155.38	119.14
Short-Term Investments	83.58	127.95	68.69	49.63	58.34	88.64
Cash & Short-Term Investments	381.32	189.07	148.92	123.64	213.72	207.78
Cash Growth	24.24%	26.96%	20.45%	-42.15%	2.86%	34.27%
Other Receivables	-	-	-	-	-	0.11
Total Trade Receivables	-	-	-	-	-	0.11
Other Current Assets	15.47	16.38	8.38	6.09	5.92	14.72
Total Current Assets	396.79	205.46	157.3	129.73	219.64	222.61
Net Property, Plant & Equipment	25.21	26.09	29.04	33.16	38.61	7.6
Other Long-Term Assets	0.89	0.99	2.32	2.04	2.01	2.16
Total Assets	422.89	232.54	188.66	164.94	260.25	232.38
Accounts Payable	5.56	3.22	4.24	2.03	3.24	4.46
Accrued Expenses	19.18	18.95	19.85	10.16	16.69	9.53
Current Portion of Leases	2.19	2.1	3.02	2.32	2.57	1.5
Unearned Revenue	-	-	-	-	-	8.08
Other Current Liabilities	3.35	9.2	3.15	-	0.01	0.04
Total Current Liabilities	30.28	33.47	30.26	14.52	22.51	23.6
Long-Term Leases	18.48	19.06	21.16	23.94	25.98	0.57
Other Long-Term Liabilities	-	-	-	-	0.1	-
Total Long-Term Liabilities	18.48	19.06	21.16	23.94	26.08	0.57
Total Liabilities	48.76	52.53	51.42	38.46	48.59	24.17
Common Stock	0.1	0.08	0.04	0.02	0.02	0.01
Additional Paid-in Capital	1,389	1,138	920.61	785.2	774.45	685.01
Accumulated Other Comprehensive Income	-0.01	0.05	0.05	0.02	-0.07	-0.05
Retained Earnings	-1,015	-957.78	-783.45	-658.75	-562.74	-476.76
Shareholders' Equity	374.13	180.01	137.25	126.48	211.67	208.21
Total Liabilities & Equity	422.89	232.54	188.66	164.94	260.25	232.38
Total Debt	20.67	21.16	24.18	26.27	28.55	2.06
Net Cash (Debt)	360.65	167.91	124.74	97.38	185.18	205.72
Net Cash Growth	114.79%	34.61%	28.11%	-47.41%	-9.98%	37.52%
Net Cash Per Share	3.67	1.92	3.06	4.90	21.75	28.90
Book Value	374.13	180.01	137.25	126.48	211.67	208.21
Book Value Per Share	3.81	2.06	3.36	6.36	24.87	29.25
Tangible Book Value	374.13	180.01	137.25	126.48	211.67	208.21
Tangible Book Value Per Share	3.81	2.06	3.36	6.36	24.87	29.25

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q